![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
|
|
|
|
|
||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication October 19, 2004.
Revised December 21, 2004.
Accepted for publication December 21, 2004.
-arrestin Dependent Spontaneous 
1a-Adrenoceptor Endocytosis causes Intracellular Transportation of -blockers via Recycling Compartments
The antagonist ligand BODIPY-FL-prazosin (QAPB) fluoresces when bound to bovine 
1a-adrenoceptors (ARs). Data indicates that the receptor-ligand complex is spontaneously internalized by 
-arrestin-dependent endocytosis. Internalization of the ligand did not occur in -arrestin-deficient cells, was blocked or reversed by another 1 ligand, phentolamine, indicating it to reflect binding to the orthosteric recognition site, and was prevented by blocking clathrin-mediated endocytosis. The ligand showed rapid, diffuse, low-intensity, surface binding, superseded by punctate intracellular binding that developed to equilibrium in 50-60 min, and was reversible on ligand removal, indicating a dynamic equilibrium. In cells expressing a human 1a-AR-EGFP2 fusion protein, BODIPY-R-558/568-prazosin (RQAPB) co-localized with the fusion, indicating that the ligand gained access to all compartments containing the receptor and, conversely, that the receptor has affinity for the ligand at all of these sites. The distribution of QAPB binding sites was similar for receptors with or without EGFP2, validating the fusion protein as an indicator of receptor location. The ligand partially co-localized with -arrestin in recycling and late endosomes indicating receptor transit without destruction. Organelles containing receptors showed considerable movement consistent with a transportation function. This was absent in -arrestin-deficient cells indicating that both constitutive receptor internalization and subsequent intracellular transportation are -arrestin-dependent. Calculations of relative receptor number suggest that at steady state less than 30% of receptors reside on the cell surface and that recyling is extremely rapid. We conclude that 1a-ARs recycle rapidly by an agonist-independent, constitutive, -arrestin-dependent process and that this can transport "-blockers" into cells carrying these receptors.
Key words:
Adrenergic, Receptor synthesis/trafficking, Sequestration/Internalization, GRKs, barrestins, Recycling, Fluorescence techniques
This article has been cited by other articles:
|
|
 |
|
  E. Oliver, D. Marti, F. Monto, N. Flacco, L. Moreno, D. Barettino, M. D. Ivorra, and P. D'Ocon The Impact of {alpha}1-Adrenoceptors Up-Regulation Accompanied by the Impairment of {beta}-Adrenergic Vasodilatation in Hypertension J. Pharmacol. Exp. Ther., March 1, 2009; 328(3): 982 - 990. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. D. Wright, Q. Chen, N. L. Baye, Y. Huang, C. L. Healy, S. Kasinathan, and T. D. O'Connell Nuclear {alpha}1-Adrenergic Receptors Signal Activated ERK Localization to Caveolae in Adult Cardiac Myocytes Circ. Res., October 24, 2008; 103(9): 992 - 1000. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Huang, C. D. Wright, S. Kobayashi, C. L. Healy, M. Elgethun, A. Cypher, Q. Liang, and T. D. O'Connell GATA4 is a survival factor in adult cardiac myocytes but is not required for {alpha}1A-adrenergic receptor survival signaling Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H699 - H707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. P. Morris, B. Lei, Y.-X. Wu, G. A. Michelotti, and D. A. Schwinn The {alpha}1a-Adrenergic Receptor Occupies Membrane Rafts with Its G Protein Effectors but Internalizes via Clathrin-coated Pits J. Biol. Chem., February 1, 2008; 283(5): 2973 - 2985. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Walwyn, C. J. Evans, and T. G. Hales {beta}-Arrestin2 and c-Src Regulate the Constitutive Activity and Recycling of {micro} Opioid Receptors in Dorsal Root Ganglion Neurons J. Neurosci., May 9, 2007; 27(19): 5092 - 5104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Lopez-Gimenez, M. Canals, J. D. Pediani, and G. Milligan The {alpha}1b-Adrenoceptor Exists as a Higher-Order Oligomer: Effective Oligomerization Is Required for Receptor Maturation, Surface Delivery, and Function Mol. Pharmacol., April 1, 2007; 71(4): 1015 - 1029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mohammad, G. Baldini, S. Granell, P. Narducci, A. M. Martelli, and G. Baldini Constitutive Traffic of Melanocortin-4 Receptor in Neuro2A Cells and Immortalized Hypothalamic Neurons J. Biol. Chem., February 16, 2007; 282(7): 4963 - 4974. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Huang, C. D. Wright, C. L. Merkwan, N. L. Baye, Q. Liang, P. C. Simpson, and T. D. O'Connell An {alpha}1A-Adrenergic-Extracellular Signal-Regulated Kinase Survival Signaling Pathway in Cardiac Myocytes Circulation, February 13, 2007; 115(6): 763 - 772. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Huston, I. Gall, T. M. Houslay, and M. D. Houslay Helix-1 of the cAMP-specific phosphodiesterase PDE4A1 regulates its phospholipase-D-dependent redistribution in response to release of Ca2+ J. Cell Sci., September 15, 2006; 119(18): 3799 - 3810. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C McGrath, C. Deighan, A. M Briones, M. M. Shafaroudi, M. McBride, J. Adler, S. M Arribas, E. Vila, and C. J Daly New aspects of vascular remodelling: the involvement of all vascular cell types Exp Physiol, July 1, 2005; 90(4): 469 - 475. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
